Fax: +49-30-84-45-44-48.
Early Detection and Diagnosis
Expression parameters of the inhibitors of apoptosis cIAP1 and cIAP2 in renal cell carcinomas and their prognostic relevance†
Article first published online: 7 DEC 2006
DOI: 10.1002/ijc.22416
Copyright © 2006 Wiley-Liss, Inc.
Additional Information
How to Cite
Kempkensteffen, C., Hinz, S., Christoph, F., Köllermann, J., Krause, H., Schrader, M., Schostak, M., Miller, K. and Weikert, S. (2007), Expression parameters of the inhibitors of apoptosis cIAP1 and cIAP2 in renal cell carcinomas and their prognostic relevance. Int. J. Cancer, 120: 1081–1086. doi: 10.1002/ijc.22416
- †
Role of the funding source: The sponsor of this study had no role in the study design; in the collection, analysis, or interpretation of the data; or in the writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Publication History
- Issue published online: 19 JAN 2007
- Article first published online: 7 DEC 2006
- Manuscript Accepted: 21 SEP 2006
- Manuscript Received: 29 JUL 2006
Funded by
- Charité – Campus Benjamin Franklin
- Universitätsmedizin Berlin
References
- 1, , . Renal-cell carcinoma. N Engl J Med 1996; 335: 865–75.
- 2. Dysregulation of apoptosis in cancer. J Clin Oncol 1999; 17: 2941–53.
- 3, . Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002; 2: 277–88.
- 4, . IAP family proteins—suppressors of apoptosis. Genes Dev 1999; 13: 239–52.
- 5, . Targeting the IAP family of caspase inhibitors as an Emerging Therapeutic Strategy. Hematology Am Soc Hematol Educ Program 2005; 215–19.
- 6, , , . Endogenous inhibitors of caspases. J Clin Immunol 1999; 19: 388–98.
- 7, , , . Caspases: the proteases of the apoptotic pathway. Oncogene 1998; 17: 3237–45.
- 8, . IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002; 3: 401–10.
- 9, , . The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol 2004; 14: 231–43.
- 10, , , . The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998; 17: 3247–59.
- 11, . Cell death regulation by the mammalian IAP antagonist Diablo/Smac. Apoptosis 2002; 7: 163–6.
- 12, , , , . Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102: 33–42.
- 13, , , , , , , , , . Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance. J Clin Oncol 2005; 23: 448–54.
- 14, , , , , , , . XIAP expression is an independent prognostic marker in clear-cell renal carcinomas. Hum Pathol 2004; 35: 1022–8.
- 15, , , , , , , , , , . Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas. Br J Cancer 2004; 91: 1349–57.
- 16, , , , , , , , . A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J 1996; 15: 2685–94.
- 17, , , , . The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995; 83: 1243–52.
- 18, . The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem 2006; 281: 3254–60.
- 19, . Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J Biol Chem 2003; 278: 10055–60.
- 20, , , , . The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 1997; 16: 6914–25.
- 21, . Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells. J Biol Chem 2004; 279: 16963–70.
- 22, , , , , , . c-IAP1 is cleaved by caspases to produce a proapoptotic C-terminal fragment. J Biol Chem 2001; 276: 7602–8.
- 23, , . TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 2002; 416: 345–7.
- 24
- 25, , , , . Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 2000; 288: 874–7.
- 26, , , , , , , . Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Int J Cancer 2002; 100: 30–6.Direct Link:
- 27, , , , , , , . Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness. Clin Cancer Res 2005; 11: 5128–39.
- 28. Renal cell carcinoma: current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80: 981–6.Direct Link:
- 29. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003; 22: 8581–9.
- 30, , , , , , . Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients. Ann Oncol 2001; 12: 799–805.
- 31, , , , , , , , , , , . Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res 2003; 9: 4914–25.
- 32, , , , , . Genomic organization and physical map of the human inhibitors of apoptosis: HIAP1 and HIAP2. Mamm Genome 1999; 10: 44–8.
- 33, , , , , . Expression and localization of inhibitor of apoptosis proteins in normal human tissues. Hum Pathol 2006; 37: 78–86.
- 34, . The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-κB-dependent antiapoptotic pathway. Cancer Res 2003; 63: 7076–80.
- 35
- 36, , , , , , , . Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma. Carcinogenesis 2002; 23: 1017–24.
- 37, , , , , , , . Expression of IAP family proteins in colon cancers from patients with different age groups. Cancer Immunol Immunother 2004; 53: 770–6.
- 38, , , , , , . Inhibitors of apoptosis proteins in human cervical cancer. BMC Cancer 2006; 6: 45.
- 39, , , , , . cIAP1 Localizes to the nuclear compartment and modulates the cell cycle. Cancer Res 2005; 65: 210–18.
- 40, , , , . Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev 2003; 17: 1487–96.
- 41, , , , . Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer. J Cancer Res Clin Oncol 2002; 128: 554–60.

1097-0215/asset/olbannerleft.jpg?v=1&s=45719cd7de57873027993264fcc568b335a8cd56)
1097-0215/asset/olbannerright.jpg?v=1&s=5e0fba63c1309b3036eb9215a0e1e83dd02efd19)
1097-0215/asset/cover.gif?v=1&s=9bea5e55449dab2cff7ad3b06277cc9745417a23)